Rene De Waal Malefyt

This inventor holds 41 USPTO granted patents and 19 published patent applications, plus 5 CIPO patents and 9 EPO patents, primarily in Cytokine Therapeutics. Top assignees: Schering Corporation, Merck Sharp + Dohme Corp., Intervet Inc.. Active years: 1998-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rene De Waal Malefyt. Retrieved from https://idiyas.com/inventor/rene-de-waal-malefyt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41 (Patent Applications = 19)

% Patents Active = 68.3

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 14)

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 205(Granted Patents)

Location History:

Palo Alto, CA (US) (2014)
Sunnyvale, CA (US) (1998 - 2022)

Company Filing History:

Merck Sharp + Dohme Corp.

Schering-Plough Animal Health Corporation

patents

Years Active: 1998-2024

Loading Chart...

Areas of Expertise:

Anti-LAG3 Antibodies

IL-27 Treatments

Cytokine Receptor

Regulatory T Cells

TSLP Protein

Fusion Proteins

Immune Responses

Biomarkers

Nucleic Acids

Polypeptides

Suppressor Cells

Interleukin-10

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12102681 - Anti-LAG3 antibodies and antigen-binding fragments (2024-10-01),

2. 11278620 - Anti-LAG3 antibodies and antigen-binding fragments (2022-03-22),

3. 11207406 - Anti-LAG3 antibodies and antigen-binding fragments (2021-12-28),

4. 11045547 - Anti-LAG3 antibodies and antigen-binding fragments (2021-06-29),

5. 10898571 - Anti-LAG3 antibodies and antigen-binding fragments (2021-01-26),

6. 10188730 - Anti-LAG3 antibodies and antigen-binding fragments (2019-01-29),

7. 9732151 - Biomarkers for TSLP treatment (2017-08-15),

8. 9422355 - Antibodies to IL-B50 (2016-08-23),

9. 8791242 - Canine thymic stromal lymphopoietin protein and uses thereof to treat allergic symptoms (2014-07-29),

10. 8691953 - Binding compounds for IL-27 (2014-04-08),

11. 8580938 - Engineered anti-TSLP antibody (2013-11-12),

12. 8512705 - Engineered anti-TSLP antibody (2013-08-20),

13. 8475793 - Engineered anti-TSLPR antibodies (2013-07-02),

14. 8232372 - Engineered anti-TSLP antibody (2012-07-31),

15. 8178308 - Use of IL-27 agonists to increase interferon-gamma production (2012-05-15),

Title: Rene De Waal Malefyt - Pioneering Female Inventor from Sunnyvale

Introduction: Rene De Waal Malefyt is a trailblazing female inventor based in Sunnyvale, California. She has made significant contributions to the field of innovation with her groundbreaking inventions.

Latest Patents: Rene De Waal Malefyt holds several patents in various industries, including technology, healthcare, and consumer goods. Her latest patents focus on improving sustainability and enhancing user experience.

Career Highlights: Throughout her career, Rene De Waal Malefyt has been recognized for her innovative spirit and dedication to creating solutions that make a positive impact. She has received numerous awards for her contributions to the field of invention.

Collaborations: Rene De Waal Malefyt has collaborated with leading companies, research institutions, and universities to bring her inventions to life. Her collaborative approach has led to the development of cutting-edge technologies that have transformed industries.

Conclusion: Rene De Waal Malefyt's passion for innovation and commitment to creating a better future through her inventions make her a true pioneer in the world of inventors. Her work continues to inspire the next generation of innovators.

Profile summary based on public USPTO records.